This site may not be displayed properly in the browser being used.
We recommend that you update to the latest browser.

It has been added to the cart.

It has been added to the comparison table.

Detail Information
  1. Top
  2. Life Science
  3. Physiology Research
  4. Active Pharmaceutical Ingredients (APIs)
  5. Hormonal Agents (for Research Use)
  6. Medroxyprogesterone Acetate
  1. Top
  2. Life Science
  3. Physiology Research
  4. Active Pharmaceutical Ingredients (APIs)
  5. Antitumor Agents (for Research Use)
  6. Medroxyprogesterone Acetate

Medroxyprogesterone Acetate

for Biochemistry
Specification Assay :
98.0+% (HPLC)
Manufacturer :
FUJIFILM Wako Pure Chemical Corporation
Storage Condition :
Keep at RT.
CAS RN® :
71-58-9
Molecular Formula :
C24H34O4
Molecular Weight :
386.52
GHS :
  • Close
  • Close
    Close
  • Close
  • Structural Formula
  • Label
  • Packing
SDS
Comparison
Product Number
Package Size
Price
Availability
Certificate of Analysis
Purchase
Distributor
138-09991
Barcode No
4987481296244
1G
List Price
51.00 USD

In stock in Japan
Distributor
Distributor
134-09993
Barcode No
4987481296251
5G
List Price
150.00 USD

In stock in Japan
Distributor

※Check  availability  in the US with the distributor.

Document

SDS
Product Specification Sheet
Spectral Data
Certificate of Analysis
Calibration Certificate

Application

Overview / Applications

Outline <Pharmacological and Physiologic Research><Hormone><Sex Hormone><Female Hormone>Primary follicles mature into Graafian follicles by the action of FSH, and begin to secrete estradiol. This estradiol causes the endometrium to proliferate, while FSH secretion is inhibited (feedback control), resulting in enhanced LH secretion. Graafian follicles are stimulated by LH, and proceed to ovulation and luteinization. LH stimulates the corpus luteum to secrete progesterone, enhances the development of uterine gland tubes and shifts the endometrium to the secretory phase (fully functioning state), while progesterone decreases oxytocin susceptibility of the uterus.Physiological effectFollicular hormone (estradiol); 1. Proliferation of endometrium2. Expression of secondary sexual characteristics3. Increased oxytocin sensitivity of the uterus4. Inhibition of FSH secretion (feedback control)Corpus luteum hormone (progesterone); 1. Changes the endometrium into a secretory phase endometrium (implantation of fertilized egg)2. Hyperthermic action (stimulation of heat center)3. Inhibition of LH secretion4. Reduction of oxytocin susceptibility of the uterus (prevention of miscarriage)Luteinizing hormone agonist having an antitumor activity. Neovascularization inhibitor. Corpus luteum hormone agonist with antitumor activity.
Luteinizing hormone agonist with antitumor activity. It has attracted attention as a neovascularization inhibitor.

Property

Appearance White - slightly brown, crystals - powder
Melting Point about 208 degrees C
Specific Rotation +45 - +51 degrees(D/20 degrees C) (c=1, dioxane)

Manufacturer Information

Alias

Same CAS list

For research use or further manufacturing use only. Not for use in diagnostic procedures.

Product content may differ from the actual image due to minor specification changes etc.

If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.

Ask for help